Supply Chain Archives
09/10/2025
Scale Smarter: How Global Supply Chain Centers Amplify CGT Program Growth
Cell and gene therapy (CGT) programs are among the most complex and sensitive operations in the life sciences. From cryopreservation and biostorage to logistics and regulatory compliance, every step in the supply chain can influence product integrity, clinical timelines, and the scalability of the program. For program heads as well as clinical and technical operations teams, the challenge becomes bigger than merely moving materials. It quickly becomes a challenge of scaling efficiently while maintaining compliance and supporting growth across a global network.
08/29/2025
The Hidden Risks in Your Supply Chain: How Regulatory Support Can Save Your CGT Program
The temperature-controlled supply chain has become so much more than a straightforward logistics function, especially for advanced therapies. It has quickly evolved into a critical extension of your manufacturing process, your clinical trials, and your path to commercialization. Every step, from sourcing raw materials to delivering the final drug product to patients, must operate within strict regulatory and quality parameters where even the smallest oversight can cascade into regulatory delays, product loss, or even compromised patient safety.
08/25/2025
What’s Next for ATMP Regulation in EMEA
For advanced therapy developers expanding into Europe, regulatory approval is just the beginning. Even after securing authorization from the European Medicines Agency (EMA), companies often find themselves mired in a patchwork of national rules, pricing hurdles, and even access delays. In her recent appearance on the Beyond Biotech podcast by Labiotech, Alison Pritchard, Vice President of Business Development for Cryoport Systems in EMEA, pulled back the curtain on what it really takes to bring advanced therapies to patients across the region.
08/20/2025
Protecting the Foundation of Biologics with Flexible, Scalable Cell Banking
For any biotherapeutic program, your cell bank is the foundation of your manufacturing process. Master cell banks (MCBs), working cell banks (WCBs), and research cell banks (RCBs), represent years of development work and intellectual property. They are irreplaceable assets, and the security of these assets is directly tied to the long-term success of your program.
08/04/2025
ATMP Development in 2025: Promise, Pressure, and the Push to Scale
As the advanced therapy medicinal products (ATMP) sector reaches the midpoint of 2025, there’s no shortage of scientific momentum. Groundbreaking CRISPR-based therapies are making headlines. Patient access to cell and gene therapies is expanding beyond early adopter markets. And a maturing global regulatory environment is slowly but surely creating new opportunities for commercialization. But alongside this promise comes pressure.
08/01/2025
Built for Speed: How Cryoport Systems Delivers Without Compromise
In the life sciences, time isn’t just money, it impacts patient outcomes, regulatory compliance, and even trial integrity. When a temperature-sensitive shipment is delayed due to inventory shipper shortages or logistical bottlenecks, the impact can cascade across an entire program. Unfortunately, these scenarios aren’t theoretical. When you’re working with irreplaceable biologic materials, this kind of disruption quickly moves from inconvenient to unacceptable.
07/31/2025
Earning the Next Trial: How Supply Chain Strategy Helps CROs Build Sponsor Trust
Contract Research Organizations (CROs) play a critical role in the biopharmaceutical industry, often executing clinical trials on behalf of sponsors. They’re tasked with wide-ranging expectations that span numerous functions, including maintaining the balance of operational excellence against regulatory compliance and cost efficiency. This complexity is compounded when clinical trial sites grow to span the globe, additional therapeutic areas, and expanded client populations. In such a competitive market, it’s not enough to simply deliver results. CROs must also build trust.
07/30/2025
Beyond Logistics: Why Clinical Trial Success Depends on a Connected Supply Chain Strategy
Contract Research Organizations (CROs) are the orchestrators of modern clinical trials. From protocol development to site management and data collection, they serve as the hidden infrastructure that brings therapies from bench to bedside. But in the increasingly global and complex research landscape, a CRO’s ability to execute doesn’t just depend on clinical expertise, it hinges on the strength of the supply chain supporting every material movement and site milestone.
07/29/2025
